Publications

Publications keep interested parties informed about the latest scientific, clinical, trial-based, and peer-reviewed documentation about our products and pipeline. Find the latest below:

sort by:

J Diabetes Sci Technol.

2015; 9(5): 1111-16

V-Go Insulin Delivery System versus Multiple Daily Insulin Injections for Patients with Uncontrolled Type 2 Diabetes Mellitus

view publication

Diabetes Ther.

2015; 6(4): 531-45

Use of V-Go® Insulin Delivery Device in Patients with Sub-optimally Controlled Diabetes Mellitus: A Retrospective Analysis from a Large Specialized Diabetes System

view publication

Diabetes Care

2015; 38(12): 2274-81

Inhaled Technosphere Insulin Versus Inhaled Technosphere Placebo in Insulin-Naïve Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetes Agents.

view publication

Diabetes Care

2015; 38(12): 2266-73

Inhaled Technosphere Insulin Compared With Injected Prandial Insulin in Type 1 Diabetes: A Randomized 24-Week Trial.

view publication

Ther. Deliv.

2013; 4(8): 939-49

Device factors affecting pulmonary delivery of dry powders.

view publication

Diabetes Technol. Ther.

2012;14: 9‍97-1‍001

Technosphere Insulin Effectively Controls Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus.

view publication

Endocr Pract.

2012; 18(5): 660-67

The V-Go Insulin Delivery Device Used in Clinical Practice: Patient Perception and Retrospective Analysis of Glycemic Control

view publication

Diabetes Obesity Metab.

2012; 14: 163-173.

Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: A randomized trial.

view publication

Pharm. Res.

2011; 28; 2‍157–2‍164

Insulin Lung Deposition and Clearance Following Technosphere® Insulin Inhalation Powder Administration

view publication

Mol. Pharmaceutics.

2008; 5(2): 294–315

A Delineation of Diketopiperazine Self-Assembly Processes: Understanding the Molecular Events Involved in Nϵ-(Fumaroyl) diketopiperazine of l-Lys (FDKP) Interactions.

view publication

J Diabetes Sci Technol.

2008; 2(1): 40-46

Basal—Prandial Insulin Delivery in Type 2 Diabetes Mellitus via the V-Go™: A Novel Continuous Subcutaneous Infusion Device

view publication

Diabetes Care

2007; 30(9):2307-8

Coverage of Postprandial Blood Glucose Excursions With Inhaled Technosphere Insulin in Comparison to Subcutaneously Injected Regular Human Insulin in Subjects With Type 2 Diabetes.

view publication
sort by:
<